Key statistics
As of last trade, Cytek Biosciences Inc (8EQ:FRA) traded at 4.66, 37.06% above the 52 week low of 3.40 set on Nov 08, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.66 |
---|---|
High | 4.66 |
Low | 4.66 |
Bid | 4.66 |
Offer | 4.82 |
Previous close | 4.52 |
Average volume | 11.56 |
---|---|
Shares outstanding | 131.51m |
Free float | 120.17m |
P/E (TTM) | -- |
Market cap | 695.66m USD |
EPS (TTM) | -0.1327 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 08:59 BST.
More ▼
Announcements
- Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
- Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
- Cytek Biosciences Announces $50 Million Stock Repurchase Program
- Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
- 1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
- Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
- Cytek Biosciences Reports First Quarter 2024 Financial Results
- Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
- Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
More ▼